Variant report
Variant | esv3472182 |
---|---|
Chromosome Location | chr6:16882973-16887971 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:2)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:16825724..16828352-chr6:16882552..16885274,2 | MCF-7 | breast: |
(count:2 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-ATXN1-4 | chr6:16886711-16886818 | NONHSAT107911 |
2 | lnc-ATXN1-4 | chr6:16886520-16886630 | NONHSAT107911 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs145960406 | chr6:16883216-16883217 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs62390964 | chr6:16883267-16883268 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs565446926 | chr6:16883299-16883300 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs564406180 | chr6:16883305-16883306 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs56092197 | chr6:16883306-16883307 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs201770455 | chr6:16883316-16883317 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs546766913 | chr6:16883366-16883367 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs34955611 | chr6:16883442-16883443 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs186148608 | chr6:16883572-16883573 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs375726120 | chr6:16883578-16883579 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs528976872 | chr6:16883589-16883590 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs548265090 | chr6:16883597-16883598 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs535652812 | chr6:16884768-16884769 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs370863295 | chr6:16884822-16884823 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs142683124 | chr6:16884922-16884923 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs112468723 | chr6:16885013-16885014 | ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs569002734 | chr6:16885038-16885039 | ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs150986688 | chr6:16885073-16885074 | ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs558112618 | chr6:16885079-16885080 | ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs577977704 | chr6:16885088-16885089 | ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs140459332 | chr6:16885103-16885104 | ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs554117784 | chr6:16885117-16885118 | ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs12201340 | chr6:16885124-16885125 | ZNF genes & repeats Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs542833392 | chr6:16885218-16885219 | ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs562707807 | chr6:16885225-16885226 | ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs182777710 | chr6:16885333-16885334 | ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs78966601 | chr6:16885376-16885377 | ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs372328780 | chr6:16885381-16885382 | ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs544797406 | chr6:16885419-16885420 | ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs564862237 | chr6:16885453-16885454 | ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs527297147 | chr6:16885479-16885480 | ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs547223038 | chr6:16885480-16885481 | ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs561472710 | chr6:16885547-16885548 | ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs553364991 | chr6:16885567-16885568 | ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs145473317 | chr6:16885572-16885573 | ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs12196917 | chr6:16885605-16885606 | ZNF genes & repeats Enhancers Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs549152907 | chr6:16885628-16885629 | ZNF genes & repeats Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
38 | rs188291132 | chr6:16885643-16885644 | ZNF genes & repeats Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
39 | rs538311406 | chr6:16885645-16885646 | ZNF genes & repeats Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
40 | rs12530252 | chr6:16885684-16885685 | ZNF genes & repeats Enhancers Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs192184496 | chr6:16885710-16885711 | ZNF genes & repeats Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
42 | rs533943525 | chr6:16885742-16885743 | ZNF genes & repeats Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
43 | rs183863585 | chr6:16885757-16885758 | ZNF genes & repeats Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
44 | rs551564899 | chr6:16885769-16885770 | ZNF genes & repeats Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
45 | rs573966927 | chr6:16885806-16885807 | ZNF genes & repeats Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
46 | rs557409575 | chr6:16885848-16885849 | ZNF genes & repeats Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
47 | rs73725267 | chr6:16885861-16885862 | ZNF genes & repeats Enhancers Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs556365328 | chr6:16885888-16885889 | ZNF genes & repeats Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
49 | rs115161430 | chr6:16885918-16885919 | ZNF genes & repeats Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
50 | rs188393264 | chr6:16886073-16886074 | ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 20164920 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Leukemia | 21518781 | CNVD |
Cancer | 21637783 | CNVD |
Facial dysmorphism | 22105932 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 19088036 | CNVD |
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Biliary cancer | 19435499 | CNVD |
Malaria | 21533027 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Prostate cancer | 18632612 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Breast cancer | 21858162 | CNVD |
Lung cancer | 18438408 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Gastric cancer | 16891809 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Autism | 21448237 | CNVD |
Cancer | 20164919 | CNVD |
Melanoma | 18172304 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Breast cancer | 22844521 | CNVD |
HIV/AIDS | 22844521 | CNVD |
Ovarian cancer | 22844521 | CNVD |
Prostate cancer | 22844521 | CNVD |
Psoriasis | 22844521 | CNVD |
Rheumatoid arthritis | 22844521 | CNVD |
Sclerosis systemic | 22844521 | CNVD |
Systemic lupus erythematosus | 22844521 | CNVD |
Breast cancer | 22522925 | CNVD |
Breast cancer | 21552322 | CNVD |
Immune disease | 21076436 | CNVD |
Autoimmune disease | 19135723 | CNVD |
Systemic lupus erythematosus | 17953491 | CNVD |
Recurrent Infections | 22737222 | CNVD |
Systemic lupus erythematosus | 21904924 | CNVD |
Ependymoma | 19289631 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Gestational infection | 22844521 | CNVD |
Head circumference | 22844521 | CNVD |
Infertility | 22844521 | CNVD |
Recurrent birth weight diabetes | 22844521 | CNVD |
Obesity | 22844521 | CNVD |
Recurrent pregnancy loss | 22844521 | CNVD |
Intellectual disability | 21811512 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Nasopharyngeal cancer | 22815911 | CNVD |
Osteosarcoma | 16790693 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Breast cancer | 17133270 | CNVD |
Autism | 22495311 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Bladder cancer | 21909424 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
abnormal development | 18461090 | CNVD |
Cancer | 16790693 | CNVD |
Breast cancer | 22032731 | CNVD |
Cervical cancer | 21062161 | CNVD |
Breast cancer | 21785460 | CNVD |
Bladder cancer | 16790693 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Retinoblastoma | 16790693 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Developmental delay | 19490664 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Lung cancer | 19153074 | CNVD |
Breast cancer | 21364760 | CNVD |
Cancer | 21183584 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:16883200-16883600 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
2 | chr6:16884600-16886000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
3 | chr6:16884600-16886000 | Enhancers | HUES64 Cell Line | embryonic stem cell |
4 | chr6:16884600-16886400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
5 | chr6:16884600-16886400 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
6 | chr6:16884800-16885200 | Enhancers | H9 Cell Line | embryonic stem cell |
7 | chr6:16884800-16885400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
8 | chr6:16884800-16885600 | Enhancers | HUES6 Cell Line | embryonic stem cell |
9 | chr6:16884800-16885600 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
10 | chr6:16885000-16886600 | ZNF genes & repeats | ES-I3 Cell Line | embryonic stem cell |
11 | chr6:16885600-16886000 | Flanking Active TSS | HUES6 Cell Line | embryonic stem cell |
12 | chr6:16886000-16886200 | Enhancers | HUES6 Cell Line | embryonic stem cell |
13 | chr6:16886000-16886400 | Enhancers | K562 | blood |
14 | chr6:16886200-16886600 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
15 | chr6:16886400-16891200 | Weak transcription | K562 | blood |
16 | chr6:16886600-16890000 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
17 | chr6:16886600-16890600 | Active TSS | HUES6 Cell Line | embryonic stem cell |